Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Plenaxis receives FDA approval

Nov. 28, 2003

Introgen and SWOG to evaluate Advexin plus surgery in phase II trial

Nov. 28, 2003

Antisoma and EMD Lexigen create immunocytokine fusion protein

Nov. 28, 2003

Preliminary phase I results on EKB-569 for advanced colorectal cancer

Nov. 28, 2003

ET-743 is associated with changes in the gene expression of sarcoma cells

Nov. 28, 2003

Metvix approved in Switzerland

Nov. 27, 2003

Novel EGFR inhibitors under study at Boehringer Ingelheim

Nov. 27, 2003

Japanese researchers describe protein kinase inhibitors as antineoplastic enhancing agents

Nov. 27, 2003

Antitumor effects of lonafarnib unrelated to Ras mutations or the PI3/Akt pathway

Nov. 27, 2003

CCI-779 in brain and pediatric tumors

Nov. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...